United Therapeutics Corporation Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
United Therapeutics (UTHR) Tops Q3 EPS by 1.10, Revenues Beat
October 28, 2020 6:16 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.88, $1.10 better than the analyst estimate of $2.78. Revenue for the quarter came in at $380.1 million versus the consensus estimate of $356.95 million.
"As our core business continues to perform well, we have a solid footing to enter 2021... More
